CHE
CHEMED CORP
NYSE · Healthcare · Medical - Care Facilities · US
$547.45
+2.59%Next report
Analyst consensus
- Next report date
- Feb 24, 2027
- EPS estimate
- $7.32
- Revenue estimate
- $711.9M
Latest reported
- Last report date
- Oct 28, 2026
- EPS actual
- $6.75
- EPS estimate
- $6.44
- Revenue actual
- $690.9M
- Revenue estimate
- $685.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +2.8%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $626
- PT range
- $585 – $675
- Analysts
- 4
3 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 28, 2026 | $6.44 | $6.75 | Beat 4.81% | $690.9M |
| Jul 29, 2026 | $5.60 | $6.06 | Beat 8.21% | $673.3M |
| Apr 24, 2026 | $5.30 | $5.65 | Beat 6.60% | $657.5M |
| Feb 26, 2026 | $7.02 | $6.42 | Miss -8.55% | $639.3M |
| Jul 29, 2025 | $4.78 | $4.27 | Miss -10.67% | $618.8M |
| Apr 23, 2025 | $5.55 | $5.63 | Beat 1.44% | $646.9M |
| Feb 26, 2025 | $6.78 | $6.83 | Beat 0.74% | $640.0M |
| Jul 24, 2024 | $5.59 | $5.47 | Miss -2.15% | $595.9M |
| Feb 27, 2024 | $6.25 | $6.60 | Beat 5.60% | $585.9M |
| Oct 25, 2023 | $4.90 | $5.32 | Beat 8.57% | $564.5M |
| Jul 26, 2023 | $5.09 | $4.71 | Miss -7.47% | $553.8M |
| Feb 23, 2023 | $5.32 | $5.39 | Beat 1.32% | $546.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 24, 2027